What amount sold does Vivos Therapeutics, Inc. report in Form D filings?

The latest linked filings report $607K sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Vivos Therapeutics, Inc.'s most recent SEC filing?

Vivos Therapeutics, Inc.'s most recent Form D filing was on 2020-02-20.

How many investors does Vivos Therapeutics, Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Vivos Therapeutics, Inc. offer?

Vivos Therapeutics, Inc.'s SEC Form D filings indicate equity offerings.

Vivos Therapeutics, Inc.

CIK: 0001716166·Biotechnology·Highlands Ranch, CO·Corporation·Founded 2016

Reported Sold

$606,500

Total Filings

Identified Offerings

Last Filed

Feb 20, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Feb 20, 2020Form D — New notice

Reported sold: $50,000 · Target: $18,000,000

Rule 506(c)·1 investor

May 16, 2019Form D — New notice

Reported sold: $556,500 · Target: $5,000,000

Rule 506(c)·9 investors

Sep 29, 2017Form D/A — Amendment

Reported sold: $0 · Target: $3,000,000

Rule 506(c)·0 investors

Changed: Offering target

Sep 28, 2017Form D — New notice

Reported sold: $0 · Target: $300,000,000

Rule 506(c)·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$2,150,000

Amendment Rate

25%

Latest reported sold across 3 identified offerings

$606,500

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

R Kirk Huntsman

Related Person

Appears on 3 filings

Gregg C.E. Johnson

Related Person

Appears on 2 filings

Edward Loew

Related Person

Appears on 2 filings

Will Meris

Related Person

Appears on 2 filings

Thomas P. Madden

Related Person

Appears on 2 filings

Terrence L. Hales

Related Person

Appears on 2 filings

Bradford Amman

Related Person

Appears on 1 filing

Gurdev Dave Singh

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 20, 2020	New	$18,000,000	$50,000	1
May 16, 2019	New	$5,000,000	$556,500	9
Sep 29, 2017	Amendment	$3,000,000	$0	0
Sep 28, 2017	New	$300,000,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Nuclein, LLC

Biotechnology

Offering target: $26,114,842

Filed Oct 27, 2026